Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2013
12/12/2013US20130331572 Processes for the preparation of sodium 5,14-dihydrotetraazapentacene polysulfonate, and intermediates thereof
12/12/2013US20130331395 Bridged aryl piperazines derivatives useful for the treatment of cns, gi-urinary and reproductive disorders
12/12/2013US20130331375 Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
12/12/2013US20130331369 3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists
12/12/2013US20130331363 Organic compounds
12/12/2013US20130330327 Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines
12/12/2013CA2875718A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013CA2875692A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013CA2875690A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013CA2874819A1 Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors
12/11/2013EP2672540A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
12/11/2013EP2671884A1 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
12/11/2013EP2671883A1 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
12/11/2013EP2671882A1 pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
12/11/2013EP2671582A1 Ring-fused heterocyclic derivative
12/11/2013EP2670754A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
12/11/2013EP2670753A1 Novel heterocyclic derivatives
12/11/2013EP2670749A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/11/2013EP2670733A2 Hdac inhibitors and therapeutic methods using the same
12/11/2013CN203333543U Complete apparatus for producing phthalocyanine cobalt sulfonate desulfurization catalyst
12/11/2013CN103443102A Bicyclic carboxamide inhibitors of kinases
12/11/2013CN103443101A Compound having fluorescent chromophore, ion concentration sensor comprising the compound, reagent comprising the compound, reagent kit provided with the reagent, precursor of the compound, and method for synthesizing the compound
12/11/2013CN103443100A Substituted 6-midazopyrazines for use as mps-1 and TKK inhibitors in the treatment of hyperproliferative disorders
12/11/2013CN103443099A Compositions and methods for modulating FXR
12/11/2013CN103442712A Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/11/2013CN103435624A Fluorinated coumarin-phthalocyanine conjugate and preparation method and application thereof
12/11/2013CN103435623A Metalloporphyrin complex and preparation method thereof, and preparation method of polycarbonate
12/11/2013CN103435622A Spiro indole diketopiperazine alkaloid, and synthesis method and application of spiro indole diketopiperazine alkaloid
12/11/2013CN103435621A Spiro quinazoline derivative and preparation method thereof
12/11/2013CN103435620A Porous copper organic framework material for CO2 adsorption and separation and preparation method of porous copper organic framework material
12/11/2013CN103435619A Pochonicine analogue or pharmaceutically acceptable salts of pochonicine analogue and application of pochonicine analogue or pharmaceutically acceptable salts of pochonicine analogue
12/11/2013CN103435618A Method for synthesizing fused-heterocycle compound
12/11/2013CN103435617A Synthesis method of 6,7-dihydro-5H-pyrrolo-[1,2-a]imidazolyl-2-formaldehyde
12/11/2013CN103435616A D(A-Ar)n type compound and application thereof
12/11/2013CN103435609A Copper-catalyzed synthetic method of imidazo[1,2-a]pyridine-3-formaldehyde compound
12/11/2013CN102617610B Preparation method of porphyrin photosensitizer and anticarcinogen diad
12/11/2013CN102464660B 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-pyrrolizine-5-acetate-butyl nitrate crystal, and preparation method and application thereof
12/11/2013CN102417509B Application of three compounds extracted from starfish to promotion of bone fracture healing, and preparation method for three compounds
12/11/2013CN102232075B Amino pyrazole compound
12/11/2013CN102040591B 7-phenyl quinolone compounds
12/11/2013CN102002047B 酞菁化合物及有机薄膜晶体管 Phthalocyanine compounds and an organic thin film transistor
12/11/2013CN101861319B Benzazepinone compound
12/11/2013CN101360746B Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
12/10/2013USRE44638 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
12/10/2013US8604043 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/10/2013US8603998 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
12/10/2013CA2767664C Compounds and compositions for the treatment of parasitic diseases
12/10/2013CA2592007C Triazolophthalazines
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/05/2013WO2013181119A1 Molecular probes for multimodality imaging and tracking of stem cells
12/05/2013WO2013180290A1 Catalyst composition for polyurethane resin production and method for producing polyurethane resin using same
12/05/2013WO2013180097A1 Organic electroluminescent element
12/05/2013WO2013179049A1 Spiro derivatives as voltage - gated sodium channel modulators
12/05/2013WO2013178572A1 Triazolo compounds as pde10 inhibitors
12/05/2013WO2013178569A1 Pyrrolidino heterocycles
12/05/2013WO2013178021A1 Pyrrole [2, 1-f][1, 2, 4] triazine derivative and antitumor effect thereof
12/05/2013WO2013177983A1 Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof
12/05/2013WO2013177668A1 Protein kinase inhibitors
12/05/2013US20130324714 Porphyrin compounds comprising one or more pyridone moieties
12/05/2013US20130324565 Organic compounds
12/05/2013US20130324562 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
12/05/2013US20130324561 Atropisomers of p13k-inhibiting compounds
12/05/2013US20130324542 [1,2,4]triazolo[4,3-b][1,2,4]triazine compounds, preparation method and use thereof
12/05/2013US20130324536 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
12/05/2013US20130324527 Imidazopyridines as respiratory syncytial virus antiviral agents
12/05/2013US20130324525 Substituted heterocyclic compounds
12/05/2013US20130324515 Imidazotriazines and imidazopyrimidines as kinase inhibitors
12/05/2013US20130324506 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
12/05/2013US20130323284 USE OF mTOR INHIBITORS TO TREAT BACTERIAL INFECTION
12/04/2013EP2669283A1 Oxazolidinone derivative having 7-membered hetero ring
12/04/2013EP2668190A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
12/04/2013EP2668189A1 New pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
12/04/2013EP2668188A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
12/04/2013EP2668187A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
12/04/2013EP2668167A1 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013EP2667870A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/04/2013CN203315791U Chlorophyll extracting solution separation tank
12/04/2013CN1989106B N-羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications
12/04/2013CN103429593A Imidazo pyrazines
12/04/2013CN103429592A 6-substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment of hyperproliferative disorders
12/04/2013CN103429591A 6 substituted imidazopyrazines for use as MPS-1 and TKK inhibitors in treatment of hyperproliferative disorders
12/04/2013CN103429576A Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof
12/04/2013CN103421027A Preparation method and application method of diazabicyclo compound
12/04/2013CN103421013A Preparation method for pyropheophorbide a
12/04/2013CN103421012A Method for preparing tricarbazole materials from aryl oxindole in one step
12/04/2013CN103421011A Method for preparing sitagliptin phosphate anhydrous crystal form I
12/04/2013CN103421005A Acetylene derivative capable of resisting activity of tumor
12/04/2013CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine
12/04/2013CN103420988A Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/04/2013CN103420977A Acetylene derivative with anti-tumor activity
12/04/2013CN101925603B Modulators of cystic fibrosis transmembrane conductance regulator
12/04/2013CN101622243B Sulfonamide derivative
12/03/2013US8598193 Polycyclic agents for the treatment of respiratory syncytial virus infections
12/03/2013US8598184 Protein kinase inhibitors
12/03/2013US8598181 Modulators of ATP-binding cassette transporters
12/03/2013US8598177 Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
12/03/2013US8598163 Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders
12/03/2013US8598155 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
12/03/2013CA2611312C Organic compounds
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 573